We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$122M
AUM Growth
-$5.34M
Cap. Flow
-$244K
Cap. Flow %
-0.2%
Top 10 Hldgs %
78.39%
Holding
51
New
–
Increased
7
Reduced
11
Closed
2

Top Buys

Rank Stock Value
1
POT
Potash Corp Of Saskatchewan
POT
+$686K
2
UPS icon
United Parcel Service
UPS
+$227K
3
T icon
AT&T
T
+$88.6K
4
TMP icon
Tompkins Financial
TMP
+$61.3K
5
SE
Spectra Energy Corp Wi
SE
+$40.8K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$378K
2
GILD icon
Gilead Sciences
GILD
+$234K
3
WU icon
Western Union
WU
+$203K
4
AAPL icon
Apple
AAPL
+$131K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$117K

Sector Composition

Rank Sector Weight
1 Healthcare 53.18%
2 Technology 26.18%
3 Communication Services 6.82%
4 Financials 3.3%
5 Consumer Discretionary 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEG icon
26
Public Service Enterprise Group
PEG
$38B
$642K 0.53%
15,222
– –
V icon
27
Visa
V
$690B
$641K 0.53%
9,200
– –
AMZN icon
28
Amazon
AMZN
$2.99T
$573K 0.47%
22,400
– –
PACB icon
29
Pacific Biosciences
PACB
$447M
$566K 0.46%
154,775
+2,200
+1% +$10.8K
AMGN icon
30
Amgen
AMGN
$210B
$485K 0.4%
3,505
– –
VZ icon
31
Verizon
VZ
$195B
$483K 0.4%
11,112
+200
+2% +$9.23K
IBM icon
32
IBM
IBM
$222B
$481K 0.39%
3,473
– –
BEN icon
33
Franklin Resources
BEN
$18.2B
$475K 0.39%
12,750
– –
BMY icon
34
Bristol-Myers Squibb
BMY
$135B
$430K 0.35%
7,270
– –
PEP icon
35
PepsiCo
PEP
$190B
$427K 0.35%
4,525
– –
SLB icon
36
SLB Ltd
SLB
$75.4B
$424K 0.35%
6,150
– –
LLY icon
37
Eli Lilly
LLY
$995B
$386K 0.32%
4,614
-900
-16% -$76K
UNFI icon
38
United Natural Foods
UNFI
$2.94B
$378K 0.31%
7,800
– –
MRK icon
39
Merck
MRK
$316B
$320K 0.26%
6,798
– –
CTSH icon
40
Cognizant
CTSH
$25.3B
$307K 0.25%
4,900
– –
MCHP icon
41
Microchip Technology
MCHP
$43.8B
$307K 0.25%
14,250
-2,020
-12% -$43.5K
HD icon
42
Home Depot
HD
$347B
$289K 0.24%
2,500
– –
STJ
43
DELISTED
St Jude Medical
STJ
$281K 0.23%
4,450
– –
BNY
44
Bank of New York Mellon
BNY
$106B
$274K 0.23%
7,000
– –
AB icon
45
AllianceBernstein
AB
$3.46B
$268K 0.22%
10,060
– –
VAR
46
DELISTED
Varian Medical Systems, Inc.
VAR
$255K 0.21%
3,934
– –
ILMN icon
47
Illumina
ILMN
$30.7B
$246K 0.2%
1,439
– –
CAT icon
48
Caterpillar
CAT
$404B
$216K 0.18%
3,300
– –
BSX icon
49
Boston Scientific
BSX
$71.1B
$189K 0.16%
11,504
– –
GILD icon
50
Gilead Sciences
GILD
$168B
– –
-2,000
Closed -$234K
1
2
3

Similar funds

PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $289M AUM 59.5% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $290M AUM 15.81% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return

Bourne Lent Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Bourne Lent Asset Management held 51 positions worth $122M, down 4.2% from $127M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 3.9%. Bourne Lent Asset Management opened no new positions and exited 2, leaving the 51-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management added most to Potash Corp Of Saskatchewan in Q3 2015, an estimated $686K increase.
  • Bourne Lent Asset Management's biggest Q3 2015 reduction was Celgene Corp, cutting an estimated $378K.
  • Bourne Lent Asset Management fully exited Gilead Sciences in Q3 2015, selling an estimated $234K.
  • Bourne Lent Asset Management's ten largest holdings make up 78% of its $122M portfolio in Q3 2015.
  • Bourne Lent Asset Management opened 0 new positions and closed 2 in Q3 2015.
  • Bourne Lent Asset Management's portfolio value fell 4.2% quarter-over-quarter to $122M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2015, filed 27 Oct 2015.